Pro-Dex Q1 revenue rises 11% helped by medical devices
PDEX•PDEX•PDEX•PDEX•Pro-Dex reported fiscal first-quarter revenue of $20.56 million, up 11% year over year, as medical device sales and a new subsidiary contributed to growth. Gross profit increased 28% to $6.86 million, while net income fell to $3.05 million.
Pro-Dex’s fiscal first-quarter revenue rose 11% year over year to $20.56 million, slightly above the $20.40 million consensus estimate. The company said medical device sales increased by $3.3 million, including $1.8 million from a next-generation handpiece sold to its largest customer. Advanced Precision Machining, a newly acquired subsidiary, contributed $511,000 in revenue excluding intercompany sales.
Gross profit rose 28% to $6.86 million, and gross margin increased to 33% from 29%, which the company attributed to favorable product mix. Net income declined year over year to $3.05 million, reflecting lower unrealized investment gains than in the prior-year period. Pro-Dex expects to ship Monogram validation units later in fiscal 2027.
